I. MPTP neurotoxicity: An overview and characterization of phases of toxicity

This publication has 8 references indexed in Scilit:

• Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors
  Nature, 1984
• Brain Enzyme Is the Target of Drug Toxin
  Science, 1984
• Trail of Ironies to Parkinson's Disease
  Science, 1984
• Parkinsonism Induced By 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine (MPTP): Implications for Treatment and the Pathogenesis of Parkinson’s Disease
  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1984
• Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey
  Brain Research, 1984
• AETIOLOGY OF PARKINSON'S DISEASE
  The Lancet, 1983
• Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
  Science, 1983
• Chronic parkinsonism secondary to intravenous injection of meperidine analogues
  Psychiatry Research, 1979